Similar articles

• The use of i.v. IG therapy in dermatology.

  Fernandez AP, Kerdel FA. Fernandez AP, et al. Dermatol Ther. 2007 Jul-Aug;20(4):288-305. doi: 10.1111/j.1529-8019.2007.00142.x. Dermatol Ther. 2007. PMID: 17970894 Review.
• [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].

  Siwińska-Gołebiowska H, Czerwińska-Kartowicz I, Markiewicz K. Siwińska-Gołebiowska H, et al. Postepy Hig Med Dosw. 2002;56 Suppl:33-40. Postepy Hig Med Dosw. 2002. PMID: 12661412 Review. Polish.
• Clinical uses of intravenous immunoglobulin.

  Jolles S, Sewell WA, Misbah SA. Jolles S, et al. Clin Exp Immunol. 2005 Oct;142(1):1-11. doi: 10.1111/j.1365-2249.2005.02834.x. Clin Exp Immunol. 2005. PMID: 16178850 Free PMC article. Review. No abstract available.
• Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.

  Simeone F, Rubio ER. Simeone F, et al. J La State Med Soc. 2003 Sep-Oct;155(5):266-9. J La State Med Soc. 2003. PMID: 14748489
• Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.

  Harvey RD 3rd. Harvey RD 3rd. Pharmacotherapy. 2005 Nov;25(11 Pt 2):71S-72S. doi: 10.1592/phco.2005.25.11part2.71S. Pharmacotherapy. 2005. PMID: 16229676 No abstract available.